RSS9 Min Read SidonMay 15, 2025 Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates AI-Powered Drug Development Pipeline Highlights: LP-300 Lantern’s Phase 2 HARMONIC™ trial for LP-300 continued to advance during Q1 2025 with…
